Publications

Publié le 24/07/2024 - Apoptose, cancer et développement

Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer.

Auteurs: Breusa S, Thomas E, Baldinotti N, Zilio S, Delcros JG, Hernandez-Palomino DM, Qi W, Guérin H, Gibert B, Mehlen P, Marigo I, Kryza D, Lollo G.

Journal: Biomater Adv.

Publié le 18/07/2024 - Apoptose, cancer et développement

Netrin signaling mediates survival of dormant epithelial ovarian cancer cells.

Auteurs: Perampalam P, MacDonald JI, Zakirova K, Passos DT, Wasif S, Ramos-Valdes Y, Hervieu M, Mehlen P, Rottapel R, Gibert B, Correa RJM, Shepherd TG, Dick FA.

Journal: Elife

Publié le 16/07/2024 - Immunosurveillance du cancer et ciblage thérapeutique

Immunogenomic profiling of the randomized NeoPembrOv clinical trial 2 reveals regulatory T cells and the VEGFR2 angiogenic axis as promising 3 actionable targets to overcome immunoresistance of high-grade ovarian 4 carcinomas.

Auteurs: Le Saux O, Ardin M, Berthet J, Barrin S, Bourhis M, Cinier J, Lounici Y, Treilleux I, Just PA, Bataillon G, Savoye AM, Mouret-Reynier MA, Coquan E, Derbel O, Jeay L, Bouizaguen S, Labidi-Galy I, Tabone-Eglinger S, Thomas E, Ménétrier-Caux C, Tartour E, Galy-Fauroux I, Stern MH, Terme M, Caux C, Dubois B*C, Ray-Coquard I

Journal: Nature Communications

Publié le 08/07/2024 -

Nonepithelial cancer dissemination: specificities and challenges

Journal:

Publié le 03/07/2024 - biologie computationnelle

TopoDoE: a design of experiment strategy for selection and refinement in ensembles of executable gene regulatory networks

Auteurs: Bouvier et al

Journal: BMC bioinformatics

Publié le 26/06/2024 - Plasticité tumorale dans le mélanome

Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients

Auteurs: Dalle S, Verronese E, N'Kodia A, Bardin C, Rodriguez C, Andrieu T, Eberhardt A, Chemin G, Hasan U, Le-Bouar M, Caramel J, Amini-Adle M, Bendriss-Vermare N, Dubois B, Caux C, Ménétrier-Caux C

Journal: Oncoimmunology